Effect of vitagnus on premenstrual syndrome

Iranian Journal of Obstetrics, Gynecology and Infertility

Volumn 17, Issue 138, 2014, Pages 1-9

  Mousavi, Parvaneh ^a   Zaheri, Hamideh ^a   Najar, Shahnaz ^a   Afshari, Pourandokht ^a   Hayati, Farkhondeh ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Plant drug; Premenstrual syndrome; Vitagnus

Indexed keywords

PLACEBO; UNCLASSIFIED DRUG; VITAGNUS; VITEX AGNUS CASTUS EXTRACT;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 84927155747     PISSN: 16802993     EISSN: 20082363     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fritz MA, Speroff L. Clinical Gynecologyic Endocrinology and Infertility, 8th ed: Wolters Kluwer; 2011. Vol 1. p.568-578.
2. Rayan Kenneth J. Kistner’s Gynecology. Translated by: Ghazi Jahani B, Ghotbi R. Seventh edition. Tehran: printed by Golshan. Golban Publications; 2008.P65
3. 3 Forrester-Knauss C, Zemp Stutz E, Weiss C, Tschudin S. The interrelation between premenstrual syndrome and major depression: results from a population-based sample. BMC Public Health 2011 Oct; 12(11):795
4. Farokh-Eslamlou H, Nabilou B, Oshnoee S, Akbari E. The prevalence of premenstrual syndrome and its associated factors among medical students of Urima university of medical science. URMIA MED J 2013: 24(9):702-710.
5. Ghare Khani P, Sadatyan S A. Cardinal manifestations & management of disease. Noordanesh Publications;2011. P 66.
6. 6 Direkvand Moghadam A, Kaikhavani S, Sayehmiri K. The Worldwide Prevalence of Premenstrual Syndrome: A Systematic Review and Meta-Analysis Study. The Iranian journal of obstetrics, Gynecology and Infertility. 2013 sep;16(65): 8-17.
7. 7 Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol. 2012 May;162(1):83-6.
8. Ramezani Tehrani F, Hashemi S, Robab Allameh M. Prevalence of premenstrual syndrome and some of its relative factors in reproductive age. Horizon Med Sci. 2012; 18 (3):121-127
9. Salehi A, Momeni H, Seraji A. Comparison of the effects of Hypericum and Vitex agnus premenstrual syndrome compared with vitamin E: a randomized clinical trial. Complementary Medicine Journal of faculty of Nursing & Midwifery 2013;3(1): 395-405.
10. Berek Jonathan S. Berek & Novak’s Gynecology1. 15th. Wolters Kluwer. 2012.Vol 1.P: 311-314.
11. https://www.acog.org/-/media/ForPatients/faq057.pdf?dmc=1&ts=20150125T0115384_73
12. Jean-Jacques D, Dugald S, Daniel P, Gideon K, Edward M. Safety and efficacy of chastetree (vitex agnus-castus) during pregnancy and lactation. The Canadian Journal of Clinical Pharmacolog. 2008 winter;15(1):e74-9.
13. Jarry H, et al. Evidence for estrogen receptor beta - selective activity of vitex agnus - castus and Isolated flavones. Planta Med. 2003 Oct; 69 (10) p:945-7.
14. Sakhavat L, Zare Tzrjany F, Kholasezade P. The effect of herbal.Vitagnus on women's Mastalgia. Southern Medical Journal. 2008 March; 11(2): 147-52.
15. Schellenberg R. “Treatment for premenstrual syndrome with agnus castus Fruit extract: prospective,. randomized, placebo controlled study.” BMJ 2001; 322: 134-137.
16. Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K. Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study. Advances in Therapy. 2014 Mar;31(3):362-73.
17. Turner S., Mills S. “A double - blind clinical trial on a herbal remedy for premenstrual syndrome: a case study.” Complementary therapies in medicine 1993. 1. P: 73-77
18. Zamani M, Neghab N, Torabian S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Medica Iranica. 2012;50(2):101-6.
19. Salami MR, Safarnejad A, Hamidi H. The effect of salinity on morphologic characteristics cumin and valerian. Research and Development Journal. 2006; 72:77-83[Persian].
20. Mortola J. F. et al. “Diagnosis of premenstrual syndrome by a simple prospective and Reliable Instrument: The calendar of premenstrual Experiences.” Obstet Gynecol: Augst 1990. Vol 76.p: 302-307
21. Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C. Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine. 2012 Nov 15;19(14):1325-31.
22. Linlin MA, Shouqing Lin, Rong Chen, Xiuli Wang. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecological Endocrinology.2010Aug;26(8): 612-616.
23. Donald J., Brown, ND. Herbal Extract Alleviates PMS Symptoms. https://www.thebetterhealthstore.com/News/PMS012501.html
24. Atmaca M, kumru S, Tezcon E. “Fluoxetine Versus vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.” Hum psychopharmacol. 2003 Apr;18(3):191-5.
25. Berger D, et al. Eifficacy of vitex agnus castus L. extract Ze 440 in patients with pre - menstrual syndrome (PMS). Arch Gynecol obstet 2000. 264; p: 150-153.